Larson Financial Group
IHE icon

Larson Financial Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Larson Financial Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.7K Hold
96
– – ﹤0.01% 2529
2026
Q2 		$9.5K Hold
96
– – ﹤0.01% 2443
2026
Q1 		$8.32K Hold
96
– – ﹤0.01% 2353
2025
Q4 		$8.14K Hold
96
– – ﹤0.01% 2235
2025
Q3 		$6.97K Buy
+96
New +$6.62K ﹤0.01% 2212

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
MinichMacGregor Wealth Management
MinichMacGregor Wealth Management Saratoga Springs, New York $620M AUM 32.35% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
Exchange Traded Concepts
Exchange Traded Concepts Oklahoma City, Oklahoma $25.3B AUM 51.52% 1-Year Est. Return
Prospera Financial Services
Prospera Financial Services Dallas, Texas $7.73B AUM 29.41% 1-Year Est. Return
McElhenny Sheffield Capital Management
McElhenny Sheffield Capital Management Dallas, Texas $431M AUM 6.99% 1-Year Est. Return
Arkansas Financial Group
Arkansas Financial Group Little Rock, Arkansas $751M AUM 9.21% 1-Year Est. Return
Well Done LLC
Well Done LLC Holland, Michigan $732M AUM 14.62% 1-Year Est. Return
Virtue Capital Management
Virtue Capital Management Brentwood, Tennessee $768M AUM 30.82% 1-Year Est. Return
Advisornet Financial
Advisornet Financial Minnetonka, Minnesota $2.21B AUM 14.38% 1-Year Est. Return

Larson Financial Group's IHE Position: Q3 2026 in Review

Larson Financial Group held its iShares US Pharmaceuticals ETF (IHE) position steady in Q3 2026 at 96 shares worth $9.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2529.

Larson Financial Group first reported a position in IHE in Q3 2025 and has held it in 5 quarters since. 126 funds tracked by Wall St. Rank hold IHE as of Q3 2026.

  • Larson Financial Group held 96 shares of iShares US Pharmaceuticals ETF worth $9.7K as of Q3 2026.
  • Larson Financial Group left its iShares US Pharmaceuticals ETF share count unchanged in Q3 2026.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2529 holding.
  • Larson Financial Group first reported a position in iShares US Pharmaceuticals ETF in Q3 2025 and has held it in 5 quarters since.
  • 126 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q3 2026.

Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.